首页 > 最新文献

Perfusion-Uk最新文献

英文 中文
The utility of sepsis scores for predicting blood stream infections in extracorporeal membrane oxygenation. 脓毒症评分对预测体外膜肺氧合中血流感染的实用性。
IF 1.2 4区 医学 Q1 Nursing Pub Date : 2024-07-01 Epub Date: 2023-03-29 DOI: 10.1177/02676591231168644
Daniel G Lee, Michal J Sobieszczyk, Alice E Barsoumian, Joseph E Marcus

Introduction: Extracorporeal membrane oxygenation (ECMO) is an increasingly used modality of life support with high risk for nosocomial infections. The accuracy of sepsis prediction tools in identifying blood stream infections (BSI) in this population is unknown as measurement of multiple variables commonly associated with infection are altered by the circuit.

Methods: This study compares all blood stream infections for patients receiving ECMO between January 2012 and December 2020 to timepoints when blood cultures were negative using the Sequential Organ Failure Assessment (SOFA), Logistic Organ Dysfunction Score (LODS), American Burn Association Sepsis Criteria (ABA), Systemic Inflammatory Response Syndrome (SIRS) scores.

Results: Of the 220 patients who received ECMO during the study period, 40 (18%) had 51 blood stream infections and were included in this study. Gram-positive infections composed 57% (n = 29) of infections with E. faecalis (n = 12, 24%) being the most common organism isolated. There were no significant differences in sepsis prediction scores at the time of infection compared to infection-free time points for SOFA (median (IQR) 7 (5-9) vs. 6 (5-8), p = 0.22), LODS (median (IQR) 12 (10-14) vs. 12 (10-13), p = 0.28), ABA (median (IQR) 2 (1-3) vs. 2 (1-3) p = 0.75), or SIRS (median (IQR) 3 (2-3) vs. 3 (2-3), p = 0.20).

Conclusions: Our data shows that previously published sepsis scores are elevated throughout a patient's ECMO course, and do not correlate with bacteremia. Better predictive tools are needed to determine the appropriate timing for blood cultures in this population.

导言:体外膜肺氧合(ECMO)是一种应用日益广泛的生命支持方式,具有很高的院内感染风险。脓毒症预测工具在识别该人群血流感染(BSI)方面的准确性尚不清楚,因为通常与感染相关的多个变量的测量会因回路而改变:本研究比较了 2012 年 1 月至 2020 年 12 月期间接受 ECMO 患者的所有血流感染情况,以及使用序贯器官功能衰竭评估 (SOFA)、逻辑器官功能障碍评分 (LODS)、美国烧伤协会败血症标准 (ABA)、全身炎症反应综合征 (SIRS) 评分对血培养结果呈阴性的时间点:在研究期间接受 ECMO 的 220 名患者中,有 40 人(18%)发生 51 例血流感染,并被纳入本研究。革兰氏阳性感染占感染总数的 57%(n = 29),其中粪大肠杆菌(n = 12,24%)是最常见的分离菌。与无感染时间点相比,感染时的脓毒症预测评分在 SOFA(中位数(IQR)7 (5-9) vs. 6 (5-8),P = 0.22)、LODS(中位数(IQR)12(10-14) vs. 12(10-13),p = 0.28)、ABA(中位数(IQR)2(1-3) vs. 2(1-3),p = 0.75)或 SIRS(中位数(IQR)3(2-3) vs. 3(2-3),p = 0.20):我们的数据显示,之前公布的败血症评分在患者的整个 ECMO 疗程中都会升高,且与菌血症无关。需要更好的预测工具来确定在这一人群中进行血液培养的适当时机。
{"title":"The utility of sepsis scores for predicting blood stream infections in extracorporeal membrane oxygenation.","authors":"Daniel G Lee, Michal J Sobieszczyk, Alice E Barsoumian, Joseph E Marcus","doi":"10.1177/02676591231168644","DOIUrl":"10.1177/02676591231168644","url":null,"abstract":"<p><strong>Introduction: </strong>Extracorporeal membrane oxygenation (ECMO) is an increasingly used modality of life support with high risk for nosocomial infections. The accuracy of sepsis prediction tools in identifying blood stream infections (BSI) in this population is unknown as measurement of multiple variables commonly associated with infection are altered by the circuit.</p><p><strong>Methods: </strong>This study compares all blood stream infections for patients receiving ECMO between January 2012 and December 2020 to timepoints when blood cultures were negative using the Sequential Organ Failure Assessment (SOFA), Logistic Organ Dysfunction Score (LODS), American Burn Association Sepsis Criteria (ABA), Systemic Inflammatory Response Syndrome (SIRS) scores.</p><p><strong>Results: </strong>Of the 220 patients who received ECMO during the study period, 40 (18%) had 51 blood stream infections and were included in this study. Gram-positive infections composed 57% (<i>n</i> = 29) of infections with <i>E. faecalis</i> (<i>n</i> = 12, 24%) being the most common organism isolated. There were no significant differences in sepsis prediction scores at the time of infection compared to infection-free time points for SOFA (median (IQR) 7 (5-9) vs. 6 (5-8), <i>p</i> = 0.22), LODS (median (IQR) 12 (10-14) vs. 12 (10-13), <i>p</i> = 0.28), ABA (median (IQR) 2 (1-3) vs. 2 (1-3) <i>p</i> = 0.75), or SIRS (median (IQR) 3 (2-3) vs. 3 (2-3), <i>p</i> = 0.20).</p><p><strong>Conclusions: </strong>Our data shows that previously published sepsis scores are elevated throughout a patient's ECMO course, and do not correlate with bacteremia. Better predictive tools are needed to determine the appropriate timing for blood cultures in this population.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9557486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A review and meta-analysis of conventional sternotomy versus minimally invasive mitral valve surgery for degenerative mitral valve disease focused on the last decade of evidence. 对传统胸骨切开术与微创二尖瓣手术治疗退行性二尖瓣疾病的回顾和荟萃分析集中于过去十年的证据。
IF 1.2 4区 医学 Q1 Nursing Pub Date : 2024-07-01 Epub Date: 2023-05-05 DOI: 10.1177/02676591231174579
Sajad Hussain, Alexander G Swystun, Massimo Caputo, Gianni D Angelini, Hunaid A Vohra

Objectives: Early meta-analyses comparing minimally invasive mitral valve surgery (MIMVS) with conventional sternotomy (CS) have determined the safety of MIMVS. We performed this review and meta-analysis based on studies from 2014 onwards to examine the differences in outcomes between MIMVS and CS. Specifically, some outcomes of interest included renal failure, new onset atrial fibrillation, mortality, stroke, reoperation for bleeding, blood transfusion and pulmonary infection.

Methods: A systematic search was performed in six databases for studies comparing MIMVS with CS. Although the initial search identified 821 papers in total, nine studies were suitable for the final analysis. All studies included compared CS with MIMVS. The Mantel - Haenszel statistical method was chosen due the use of inverse variance and random effects. A meta-analysis was performed on the data.

Results: MIMVS had significantly lower odds of renal failure (OR: 0.52; 95% CI 0.37 to 0.73, p < 0.001), new onset atrial fibrillation (OR: 0.78; 95% CI 0.67 to 0.90, p < 0.001), reduced prolonged intubation (OR: 0.50; 95% CI 0.29 to 0.87, p = 0.01) and reduced mortality (OR: 0.58; 95% CI 0.38 to 0.87, p < 0.01). MIMVS had shorter ICU stay (WMD: -0.42; 95% CI -0.59 to -0.24, p < 0.001) and shorter time to discharge (WMD: -2.79; 95% CI -3.86 to -1.71, p < 0.001).

Conclusion: In the modern era, MIMVS for degenerative disease is associated with improved short-term outcomes when compared to the CS.

目的:早期荟萃分析比较了微创二尖瓣手术(MIMVS)和传统胸骨切开术(CS),确定了微创二尖瓣手术的安全性。我们对 2014 年以来的研究进行了回顾和荟萃分析,以研究 MIMVS 和 CS 在结果上的差异。具体而言,我们关注的一些结果包括肾衰竭、新发房颤、死亡率、中风、因出血再次手术、输血和肺部感染:方法:在六个数据库中对 MIMVS 与 CS 的比较研究进行了系统检索。尽管初步检索共发现了 821 篇论文,但有 9 项研究适合进行最终分析。所有纳入的研究都对 CS 与 MIMVS 进行了比较。由于使用了反方差和随机效应,因此选择了 Mantel - Haenszel 统计方法。对数据进行了荟萃分析:MIMVS明显降低了肾衰竭(OR:0.52;95% CI 0.37 至 0.73,p < 0.001)、新发心房颤动(OR:0.78;95% CI 0.67 至 0.90,p < 0.001)、延长插管时间(OR:0.50;95% CI 0.29 至 0.87,p = 0.01)和死亡率(OR:0.58;95% CI 0.38 至 0.87,p < 0.01)的几率。MIMVS的ICU住院时间更短(WMD:-0.42;95% CI -0.59至-0.24,p <0.001),出院时间更短(WMD:-2.79;95% CI -3.86至-1.71,p <0.001):结论:在现代社会,与 CS 相比,MIMVS 治疗退行性疾病可改善短期疗效。
{"title":"A review and meta-analysis of conventional sternotomy versus minimally invasive mitral valve surgery for degenerative mitral valve disease focused on the last decade of evidence.","authors":"Sajad Hussain, Alexander G Swystun, Massimo Caputo, Gianni D Angelini, Hunaid A Vohra","doi":"10.1177/02676591231174579","DOIUrl":"10.1177/02676591231174579","url":null,"abstract":"<p><strong>Objectives: </strong>Early meta-analyses comparing minimally invasive mitral valve surgery (MIMVS) with conventional sternotomy (CS) have determined the safety of MIMVS. We performed this review and meta-analysis based on studies from 2014 onwards to examine the differences in outcomes between MIMVS and CS. Specifically, some outcomes of interest included renal failure, new onset atrial fibrillation, mortality, stroke, reoperation for bleeding, blood transfusion and pulmonary infection.</p><p><strong>Methods: </strong>A systematic search was performed in six databases for studies comparing MIMVS with CS. Although the initial search identified 821 papers in total, nine studies were suitable for the final analysis. All studies included compared CS with MIMVS. The Mantel - Haenszel statistical method was chosen due the use of inverse variance and random effects. A meta-analysis was performed on the data.</p><p><strong>Results: </strong>MIMVS had significantly lower odds of renal failure (OR: 0.52; 95% CI 0.37 to 0.73, <i>p</i> < 0.001), new onset atrial fibrillation (OR: 0.78; 95% CI 0.67 to 0.90, <i>p</i> < 0.001), reduced prolonged intubation (OR: 0.50; 95% CI 0.29 to 0.87, <i>p</i> = 0.01) and reduced mortality (OR: 0.58; 95% CI 0.38 to 0.87, <i>p</i> < 0.01). MIMVS had shorter ICU stay (WMD: -0.42; 95% CI -0.59 to -0.24, <i>p</i> < 0.001) and shorter time to discharge (WMD: -2.79; 95% CI -3.86 to -1.71, <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>In the modern era, MIMVS for degenerative disease is associated with improved short-term outcomes when compared to the CS.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9782464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-distance donor heart procurement using an innovative cold static storage system. 利用创新的冷冻静态储存系统进行远距离心脏捐献。
IF 1.1 4区 医学 Q1 Nursing Pub Date : 2024-07-01 Epub Date: 2023-03-11 DOI: 10.1177/02676591231163018
Martin O Schmiady, Leszek P Bec, Mohammed Shallah, Andreas J Flammer, Paul R Vogt, Markus J Wilhelm

The global lack of donor shortage poses a major limitation for heart transplantation. New concepts with expanded donor inclusion criteria comprise extended transport distances and prolonged ischemic times with the aim of reaching a larger number of potential donors. Recent developments in cold storage solutions may allow more donor hearts with prolonged ischemic times to be use for transplantation in the future. We present our experience during a long-distance donor heart procurement with the longest reported transport distance and transport time in the current literature. This was made possible through the use of SherpaPak™, an innovative cold storage system which allows for controlled temperatures during transportation.

全球供体短缺是心脏移植的主要限制因素。扩大供体纳入标准的新概念包括延长运输距离和延长缺血时间,目的是接触到更多的潜在供体。冷藏解决方案的最新发展可能会使更多缺血时间较长的供体心脏在未来用于移植。我们介绍了我们在一次长途捐献心脏采购中的经验,这是目前文献报道中运输距离和运输时间最长的一次。通过使用创新型冷藏系统 SherpaPak™,我们得以在运输过程中控制温度。
{"title":"Long-distance donor heart procurement using an innovative cold static storage system.","authors":"Martin O Schmiady, Leszek P Bec, Mohammed Shallah, Andreas J Flammer, Paul R Vogt, Markus J Wilhelm","doi":"10.1177/02676591231163018","DOIUrl":"10.1177/02676591231163018","url":null,"abstract":"<p><p>The global lack of donor shortage poses a major limitation for heart transplantation. New concepts with expanded donor inclusion criteria comprise extended transport distances and prolonged ischemic times with the aim of reaching a larger number of potential donors. Recent developments in cold storage solutions may allow more donor hearts with prolonged ischemic times to be use for transplantation in the future. We present our experience during a long-distance donor heart procurement with the longest reported transport distance and transport time in the current literature. This was made possible through the use of SherpaPak™, an innovative cold storage system which allows for controlled temperatures during transportation.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9140893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Soluble ST2 predicts continuous renal replacement therapy in patients receiving venoarterial extracorporeal membrane oxygenation. 可溶性 ST2 预测接受静脉体外膜氧合患者的持续肾脏替代疗法。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2023-04-13 DOI: 10.1177/02676591231169410
Chengcheng Shao, Yu Cao, Zengtao Wang, Xiaomeng Wang, Chenglong Li, Xing Hao, Liangshan Wang, Zhongtao Du, Feng Yang, Chunjing Jiang, Hong Wang, Yu Hao, Junyan Han, Xiaotong Hou

Objective: This study aimed to evaluate the relationship between plasma soluble ST2 (sST2) levels 24 h after extracorporeal membrane oxygenation (ECMO) initiation and continuous renal replacement therapy (CRRT) in patients receiving venoarterial ECMO (V-A ECMO) support.

Methods and results: Data of patients who received ECMO support for postcardiotomy cardiogenic shock between January 2017 and July 2019 were retrospectively collected from Beijing Anzhen Hospital, Capital Medical University. Ultimately, 116 patients were included in the present study for analysis. The concentration of sST2 was determined by enzyme-linked immunosorbent assay (ELISA). The log10 sST2 levels were higher in patients undergoing CRRT than those who did not (6.06 vs. 6.22, p = 0.019). Patients undergoing CRRT had a lower survival rate than those who did not (32.8% vs. 67.3%, p < 0.001). In the univariate logistic regression analysis, sST2, HCO3-, lactate, and creatinine levels 24 h after ECMO initiation were related to CRRT (p < 0.05). In the multivariate logistic regression analysis, HCO3- and sST2 were identified as independent risk factors for CRRT use in patients undergoing ECMO (p < 0.05). The area under receiver operator characteristic curve (AUC) for sST2 and HCO3- together was 0.72 (95% confidence interval (CI), 0.79-0.91), which was better than those of sST2 or HCO3- alone (0.63 vs. 0.67).

Conclusions: sST2 and HCO3-levels at 24 h after ECMO initiation were associated with CRRT and could predict CRRT use in postcardiotomy cardiogenic shock patients undergoing ECMO.

研究目的本研究旨在评估接受静脉动脉ECMO(V-A ECMO)支持的患者在体外膜肺氧合(ECMO)启动24 h后血浆可溶性ST2(sST2)水平与持续肾脏替代治疗(CRRT)之间的关系:回顾性收集首都医科大学附属北京安贞医院2017年1月至2019年7月期间因心肌梗死术后心源性休克接受ECMO支持的患者数据。最终,116 例患者纳入本研究进行分析。采用酶联免疫吸附试验(ELISA)测定 sST2 的浓度。接受 CRRT 治疗的患者 sST2 的 log10 水平高于未接受 CRRT 治疗的患者(6.06 vs. 6.22,P = 0.019)。接受 CRRT 治疗的患者存活率低于未接受 CRRT 治疗的患者(32.8% 对 67.3%,P < 0.001)。在单变量逻辑回归分析中,ECMO 启动 24 小时后的 sST2、HCO3-、乳酸和肌酐水平与 CRRT 有关(P < 0.05)。在多变量逻辑回归分析中,HCO3- 和 sST2 被确定为 ECMO 患者使用 CRRT 的独立风险因素(P < 0.05)。结论:ECMO 启动后 24 小时内的 sST2 和 HCO3 水平与 CRRT 相关,可预测接受 ECMO 的心肌梗死后心源性休克患者使用 CRRT 的情况。
{"title":"Soluble ST2 predicts continuous renal replacement therapy in patients receiving venoarterial extracorporeal membrane oxygenation.","authors":"Chengcheng Shao, Yu Cao, Zengtao Wang, Xiaomeng Wang, Chenglong Li, Xing Hao, Liangshan Wang, Zhongtao Du, Feng Yang, Chunjing Jiang, Hong Wang, Yu Hao, Junyan Han, Xiaotong Hou","doi":"10.1177/02676591231169410","DOIUrl":"10.1177/02676591231169410","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the relationship between plasma soluble ST2 (sST2) levels 24 h after extracorporeal membrane oxygenation (ECMO) initiation and continuous renal replacement therapy (CRRT) in patients receiving venoarterial ECMO (V-A ECMO) support.</p><p><strong>Methods and results: </strong>Data of patients who received ECMO support for postcardiotomy cardiogenic shock between January 2017 and July 2019 were retrospectively collected from Beijing Anzhen Hospital, Capital Medical University. Ultimately, 116 patients were included in the present study for analysis. The concentration of sST2 was determined by enzyme-linked immunosorbent assay (ELISA). The log<sub>10</sub> sST2 levels were higher in patients undergoing CRRT than those who did not (6.06 <i>vs</i>. 6.22, <i>p</i> = 0.019). Patients undergoing CRRT had a lower survival rate than those who did not (32.8% <i>vs</i>. 67.3%, <i>p</i> < 0.001). In the univariate logistic regression analysis, sST2, HCO<sub>3</sub><sup>-</sup>, lactate, and creatinine levels 24 h after ECMO initiation were related to CRRT (<i>p</i> < 0.05). In the multivariate logistic regression analysis, HCO<sub>3</sub><sup>-</sup> and sST2 were identified as independent risk factors for CRRT use in patients undergoing ECMO (<i>p</i> < 0.05). The area under receiver operator characteristic curve (AUC) for sST2 and HCO<sub>3</sub><sup>-</sup> together was 0.72 (95% confidence interval (CI), 0.79-0.91), which was better than those of sST2 or HCO<sub>3</sub><sup>-</sup> alone (0.63 <i>vs</i>. 0.67).</p><p><strong>Conclusions: </strong>sST2 and HCO<sub>3</sub><sup>-</sup>levels at 24 h after ECMO initiation were associated with CRRT and could predict CRRT use in postcardiotomy cardiogenic shock patients undergoing ECMO.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9290279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tomographic 3D ultrasound for grading stenosis of superficial femoral artery. 用于股浅动脉狭窄分级的断层 3D 超声波。
IF 1.2 4区 医学 Q1 Nursing Pub Date : 2024-07-01 Epub Date: 2023-04-17 DOI: 10.1177/02676591231169852
Adel Alzahrani, Salahaden R Sultan, Mohammed Aslam

Introduction: Treatment decision of lower extremity peripheral arterial disease (PAD) is governed by the severity of stenosis. Tomographic 3D ultrasound (t3DUS) is a reliable imaging technique for measuring vessel stenosis. In this study we attempted to provide a precise measurement of superficial femoral artery (SFA) stenosis using t3DUS in patients with PAD.

Methods: t3DUS was used to measure maximum stenosis percentage in SFA from 50 patients with lower extremity PAD. The maximum stenosed segment in SFA was defined using Duplex 2DUS aliasing was noted. The peak systolic velocity (PSV) was measured at the maximum stenotic site and proximal to aliasing for calculating the velocity ratio. The association between blood flow velocity ratio and the degree of stenosis measured using Duplex 2DUS and t3DUS, respectively, was assessed using Spearman rank correlation.

Results: There was a strong positive correlation between velocity ratio and degree of stenosis in SFA measured using t3DUS (correlation value (r) = 0.99, p < 0.001). The correlation between Stenosis percentage and velocity ratio in SFA are as followed: <50:<2; 50-54:2-2.4; 55-59:2.5-2.9; 60-64:3-3.4; 65-69:3.5-3.9; 70-74:4-4.4; 75-79:4.5-4.9; >80:>5.

t3DUS can be used to provide precise measurement of the severity of SFA stenosis in patients with lower extremities arterial disease. The established criteria for grading SFA stenosis in this study can be applied to the current practice alongside Duplex 2DUS as it showed a strong positive correlation with velocity ratio. Further studies investigating the sensitivity and specificity of t3DUS in the assessment of stenosis in lower limbs arteries are required.

简介:下肢外周动脉疾病(PAD)的治疗决策取决于血管狭窄的严重程度。断层三维超声(t3DUS)是测量血管狭窄程度的可靠成像技术。在这项研究中,我们尝试使用 t3DUS 对 PAD 患者的股浅动脉 (SFA) 狭窄程度进行精确测量。方法:使用 t3DUS 测量 50 名下肢 PAD 患者的 SFA 最大狭窄率。在最大狭窄部位和别离近端测量收缩峰值速度(PSV)以计算速度比。使用斯皮尔曼秩相关法评估了血流速度比与分别使用双相二维超声和三维超声测量的狭窄程度之间的关系:结果:使用 t3DUS 测量的速度比与 SFA 狭窄程度之间存在很强的正相关性(相关值 (r) = 0.99,p < 0.001)。SFA 狭窄百分比与速度比之间的相关性如下:t3DUS可用于精确测量下肢动脉疾病患者的SFA狭窄严重程度。这项研究中确定的 SFA 狭窄分级标准可与双相 2DUS 一起应用于当前的实践中,因为它与速度比值显示出很强的正相关性。还需要进一步研究 t3DUS 在评估下肢动脉狭窄方面的敏感性和特异性。
{"title":"Tomographic 3D ultrasound for grading stenosis of superficial femoral artery.","authors":"Adel Alzahrani, Salahaden R Sultan, Mohammed Aslam","doi":"10.1177/02676591231169852","DOIUrl":"10.1177/02676591231169852","url":null,"abstract":"<p><strong>Introduction: </strong>Treatment decision of lower extremity peripheral arterial disease (PAD) is governed by the severity of stenosis. Tomographic 3D ultrasound (t3DUS) is a reliable imaging technique for measuring vessel stenosis. In this study we attempted to provide a precise measurement of superficial femoral artery (SFA) stenosis using t3DUS in patients with PAD.</p><p><strong>Methods: </strong>t3DUS was used to measure maximum stenosis percentage in SFA from 50 patients with lower extremity PAD. The maximum stenosed segment in SFA was defined using Duplex 2DUS aliasing was noted. The peak systolic velocity (PSV) was measured at the maximum stenotic site and proximal to aliasing for calculating the velocity ratio. The association between blood flow velocity ratio and the degree of stenosis measured using Duplex 2DUS and t3DUS, respectively, was assessed using Spearman rank correlation.</p><p><strong>Results: </strong>There was a strong positive correlation between velocity ratio and degree of stenosis in SFA measured using t3DUS (correlation value <i>(r)</i> = 0.99, <i>p</i> < 0.001). The correlation between Stenosis percentage and velocity ratio in SFA are as followed: <50:<2; 50-54:2-2.4; 55-59:2.5-2.9; 60-64:3-3.4; 65-69:3.5-3.9; 70-74:4-4.4; 75-79:4.5-4.9; >80:>5.</p><p><p>t3DUS can be used to provide precise measurement of the severity of SFA stenosis in patients with lower extremities arterial disease. The established criteria for grading SFA stenosis in this study can be applied to the current practice alongside Duplex 2DUS as it showed a strong positive correlation with velocity ratio. Further studies investigating the sensitivity and specificity of t3DUS in the assessment of stenosis in lower limbs arteries are required.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9318332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iliopsoas haematoma during extracorporeal membrane oxygenation: A registry report from the COVID-19 critical care consortium across 30 countries. 体外膜氧合过程中的髂腰部血肿:来自 30 个国家的 COVID-19 重症监护联盟的登记报告。
IF 1.2 4区 医学 Q1 Nursing Pub Date : 2024-07-01 Epub Date: 2023-03-29 DOI: 10.1177/02676591231168285
Hayato Taniguchi, Indrek Rätsep, Silver Heinsar, Keibun Liu, Marcela Cespedes, Jacky Y Suen, Gianluigi Li Bassi, John F Fraser, Jeffrey P Jacobs, Giles J Peek

Introduction: Iliopsoas haematoma (IPH) during extracorporeal membrane oxygenation (ECMO) is a rare bleeding complication that can be fatal due to its progression to abdominal compartment syndrome, but its incidence and risk factors are not well known. We have previously reported an IPH incidence rate of 16% in Japan. Among possible reasons for this high incidence, ethnicity has been hypothesised to play a role. Therefore, we used an international multi-centre cohort registry to test this hypothesis by determining the incidence rate of IPH.

Methods: This study was performed using the COVID-19 Critical Care Consortium database, conducted in 30 countries across five continents between 3 January 2020, and 20 June 2022.

Results: Overall, 1102 patients received ECMO for COVID-19-related acute respiratory distress syndrome. Of them, only seven were reported to have IPH, indicating an incidence rate of 0.64%, with comparable rates between the countries. The IPH group tended to have a higher mortality rate (71.4%) than the non-IPH group (51%).

Conclusions: Overall incidence of IPH in the studied COVID-19 ECMO cohort was 0.64%. Most cases were reported from Japan, Belgium, and Italy. In our study, this rare complication did not appear to be confined to Asian patients. Due to the high fatality rate, awareness about the occurrence of IPH should be recognised.

导言:体外膜肺氧合(ECMO)期间的髂腰部血肿(IPH)是一种罕见的出血并发症,可因发展为腹腔室综合征而致命,但其发病率和风险因素尚不十分清楚。我们曾报道日本的 IPH 发生率为 16%。在这一高发病率的可能原因中,种族因素被认为是一个重要因素。因此,我们利用国际多中心队列登记,通过确定 IPH 的发病率来验证这一假设:本研究使用 COVID-19 重症监护联盟数据库,于 2020 年 1 月 3 日至 2022 年 6 月 20 日期间在五大洲的 30 个国家进行:共有 1102 名患者因 COVID-19 相关急性呼吸窘迫综合征而接受了 ECMO。其中,仅有 7 人报告患有 IPH,发病率为 0.64%,各国发病率相当。IPH组的死亡率(71.4%)往往高于非IPH组(51%):结论:在研究的 COVID-19 ECMO 队列中,IPH 的总体发病率为 0.64%。大多数病例来自日本、比利时和意大利。在我们的研究中,这种罕见的并发症似乎并不局限于亚洲患者。由于其致死率较高,人们应该认识到 IPH 的发生。
{"title":"Iliopsoas haematoma during extracorporeal membrane oxygenation: A registry report from the COVID-19 critical care consortium across 30 countries.","authors":"Hayato Taniguchi, Indrek Rätsep, Silver Heinsar, Keibun Liu, Marcela Cespedes, Jacky Y Suen, Gianluigi Li Bassi, John F Fraser, Jeffrey P Jacobs, Giles J Peek","doi":"10.1177/02676591231168285","DOIUrl":"10.1177/02676591231168285","url":null,"abstract":"<p><strong>Introduction: </strong>Iliopsoas haematoma (IPH) during extracorporeal membrane oxygenation (ECMO) is a rare bleeding complication that can be fatal due to its progression to abdominal compartment syndrome, but its incidence and risk factors are not well known. We have previously reported an IPH incidence rate of 16% in Japan. Among possible reasons for this high incidence, ethnicity has been hypothesised to play a role. Therefore, we used an international multi-centre cohort registry to test this hypothesis by determining the incidence rate of IPH.</p><p><strong>Methods: </strong>This study was performed using the COVID-19 Critical Care Consortium database, conducted in 30 countries across five continents between 3 January 2020, and 20 June 2022.</p><p><strong>Results: </strong>Overall, 1102 patients received ECMO for COVID-19-related acute respiratory distress syndrome. Of them, only seven were reported to have IPH, indicating an incidence rate of 0.64%, with comparable rates between the countries. The IPH group tended to have a higher mortality rate (71.4%) than the non-IPH group (51%).</p><p><strong>Conclusions: </strong>Overall incidence of IPH in the studied COVID-19 ECMO cohort was 0.64%. Most cases were reported from Japan, Belgium, and Italy. In our study, this rare complication did not appear to be confined to Asian patients. Due to the high fatality rate, awareness about the occurrence of IPH should be recognised.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064192/pdf/10.1177_02676591231168285.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9592362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Propofol during cardiopulmonary bypass for prolonged hypotensive use and potential adverse effects. 在心肺旁路术中长期使用丙泊酚降血压和潜在的不良反应。
IF 1.2 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2023-05-03 DOI: 10.1177/02676591231174581
Ignazio Condello
{"title":"Propofol during cardiopulmonary bypass for prolonged hypotensive use and potential adverse effects.","authors":"Ignazio Condello","doi":"10.1177/02676591231174581","DOIUrl":"10.1177/02676591231174581","url":null,"abstract":"","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9769000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal membrane oxygenation in 34 days old infant with SARS-COV-2 associated pneumonia. 体外膜肺氧合治疗 34 天大的 SARS-COV-2 相关肺炎婴儿。
IF 1.1 4区 医学 Q1 Nursing Pub Date : 2024-07-01 Epub Date: 2023-04-09 DOI: 10.1177/02676591231169853
Aleh Zhuk, Aliaksei Tsylko, Viktoryia Nazarava, Anna Migun

We present a case of successful veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in infant with SARS-COV-2 associated pneumonia. To the best of our knowledge, this patient was the youngest infant successfully discharged after the VA-ECMO for COVID-19. We report one complication of ECMO support, which was bleeding from the site of the radial artery cannulation. We followed up this patient for 6 months after the discharge: delayed psychomotor development and inability to swallow were noted. Follow-up CT 3 months after the discharge showed linear fibrosis of S5 lung segment.

我们在此介绍一例成功为 SARS-COV-2 相关肺炎婴儿进行静脉-动脉体外膜氧合(VA-ECMO)的病例。据我们所知,该患者是因 COVID-19 而接受 VA-ECMO 后成功出院的年龄最小的婴儿。我们报告了 ECMO 支持的一个并发症,即桡动脉插管部位出血。出院后,我们对该患者进行了 6 个月的随访:发现其精神运动发育迟缓且无法吞咽。出院 3 个月后的随访 CT 显示,S5 肺段出现线性纤维化。
{"title":"Extracorporeal membrane oxygenation in 34 days old infant with SARS-COV-2 associated pneumonia.","authors":"Aleh Zhuk, Aliaksei Tsylko, Viktoryia Nazarava, Anna Migun","doi":"10.1177/02676591231169853","DOIUrl":"10.1177/02676591231169853","url":null,"abstract":"<p><p>We present a case of successful veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in infant with SARS-COV-2 associated pneumonia. To the best of our knowledge, this patient was the youngest infant successfully discharged after the VA-ECMO for COVID-19. We report one complication of ECMO support, which was bleeding from the site of the radial artery cannulation. We followed up this patient for 6 months after the discharge: delayed psychomotor development and inability to swallow were noted. Follow-up CT 3 months after the discharge showed linear fibrosis of S5 lung segment.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9264060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hereditary angioedema in cardiac surgery: Perioperative management considerations for a rare disease. 心脏手术中的遗传性血管性水肿:一种罕见疾病的围手术期管理注意事项。
IF 1.2 4区 医学 Q1 Nursing Pub Date : 2024-07-01 Epub Date: 2023-05-08 DOI: 10.1177/02676591231174773
Enrica Chiara Adami, Federica Magri, Chiara Plotti, Stefania Renzi, Giovanni Chiarini, Giuseppe De Cicco

Introduction: Hereditary Angioedema is a rare disease caused by C1 esterase inhibitor deficiency leading to diffuse and potentially life-threatening oedema formation. Preventing attacks is critical, particularly for patients undergoing cardiac surgery.

Case report: We report a case of a 71-years-old woman with a history of Hereditary Angioedema scheduled for open-heart surgery on Cardiopulmonary Bypass. Multidisciplinar teamwork and patient-targeted strategy were crucial to obtain a favorable outcome.

Discussion: Cardiac surgery is a major stressor for Angioedema attacks because of Complement cascade and inflammatory response activation leading to potential life-threatening oedema formation. In literature only few cases of complex open heart surgery under Cardiopulmonary Bypass are described.

Conclusion: Continuous updating and multidisciplinarity are key elements to manage patients with Hereditary Angioedema in cardiac surgery in order to reduce morbidity and mortality.

简介遗传性血管性水肿是一种罕见疾病,由 C1 酯酶抑制剂缺乏引起,可导致弥漫性水肿,并可能危及生命。预防发作至关重要,尤其是对接受心脏手术的患者:我们报告了一例 71 岁女性的病例,她有遗传性血管性水肿病史,计划接受心肺旁路开胸手术。多学科团队合作和以患者为目标的策略是取得良好结果的关键:讨论:心脏手术是血管性水肿发作的主要应激因素,因为补体级联反应和炎症反应激活可能导致水肿形成,危及生命。文献中只有极少数在心肺旁路下进行复杂开胸手术的病例:结论:不断更新和多学科合作是管理心脏手术中遗传性血管性水肿患者的关键因素,以降低发病率和死亡率。
{"title":"Hereditary angioedema in cardiac surgery: Perioperative management considerations for a rare disease.","authors":"Enrica Chiara Adami, Federica Magri, Chiara Plotti, Stefania Renzi, Giovanni Chiarini, Giuseppe De Cicco","doi":"10.1177/02676591231174773","DOIUrl":"10.1177/02676591231174773","url":null,"abstract":"<p><strong>Introduction: </strong>Hereditary Angioedema is a rare disease caused by C1 esterase inhibitor deficiency leading to diffuse and potentially life-threatening oedema formation. Preventing attacks is critical, particularly for patients undergoing cardiac surgery.</p><p><strong>Case report: </strong>We report a case of a 71-years-old woman with a history of Hereditary Angioedema scheduled for open-heart surgery on Cardiopulmonary Bypass. Multidisciplinar teamwork and patient-targeted strategy were crucial to obtain a favorable outcome.</p><p><strong>Discussion: </strong>Cardiac surgery is a major stressor for Angioedema attacks because of Complement cascade and inflammatory response activation leading to potential life-threatening oedema formation. In literature only few cases of complex open heart surgery under Cardiopulmonary Bypass are described.</p><p><strong>Conclusion: </strong>Continuous updating and multidisciplinarity are key elements to manage patients with Hereditary Angioedema in cardiac surgery in order to reduce morbidity and mortality.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9432392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of a modified, low-cost, veno-arterial extracorporeal membrane oxygenation (V-A ECMO) for elective, periprocedural support of high-risk percutaneous cardiac interventions: An experience from a latinamerican center. 改良型低成本静脉-动脉体外膜肺氧合(V-A ECMO)用于高风险经皮心脏介入手术的择期、围手术期支持的效果:来自拉丁美洲中心的经验。
IF 1.2 4区 医学 Q1 Nursing Pub Date : 2024-07-01 Epub Date: 2023-05-24 DOI: 10.1177/02676591231178413
Juan F Bulnes, Alejandro Martínez, Pablo Sepúlveda, Alberto Fuensalida, Santiago Besa, Luis Garrido, Gonzalo Martínez

Introduction: High-risk procedures in interventional cardiology include a wide spectrum of clinical and anatomical scenarios related to a higher periprocedural morbidity and mortality. The prophylactic use of short-term mechanical circulatory support (ST-MCS) may improve both the safety and efficacy of the intervention by leading to more stable procedural hemodynamics. However, the significant costs may limit its use in resource constrained settings. To overcome this limitation, we ideated a modified, low-cost, veno-arterial extracorporeal membrane oxygenator (V-A ECMO) setup.

Methods: We conducted an observational prospective study including all patients undergoing a high-risk interventional cardiology procedure at our institution under prophylactic ST-MCS using a modified, low-cost version of V-A ECMO, where some components of the standard V-A ECMO circuit were replaced by supplies used for cardiac surgical cardiopulmonary bypass, achieving a cost reduction of 72%. We assessed in-hospital and mid-term outcomes, including procedural success, post-procedure complications and mortality.

Results: Between March 2016 and December 2021, ten patients underwent high-risk IC procedures with prophylactic use of V-A ECMO. Isolated percutaneous intervention (PCI) was performed in six patients, isolated transcatheter aortic valve replacement (TAVR) in two, and a combined procedure (PCI + TAVR) in two. Mean ejection fraction was 34% (range 20-64%). Mean STS PROM was 16.2% (range 9.5-35.8%) and mean EuroScore was 23.7% (range 1.5-60%). The planned intervention was successfully performed in all cases. There were no reports of V-A ECMO malfunction. In nine patients the VA-ECMO was withdrawn immediately after the procedure but one patient required extended - 24 h - support with no significant issues. One patient experienced a periprocedural myocardial infarction and another developed a femoral pseudoaneurysm. In-hospital and 30-day survival were 100%, and 1-year survival was 80%.

Conclusions: High-risk procedures in interventional cardiology can be successfully performed under prophylactic ST-MCS using a modified, low-cost V-A ECMO, suitable for limited-resource settings.

导言:介入心脏病学中的高风险手术包括与较高围手术期发病率和死亡率有关的各种临床和解剖情况。预防性使用短期机械循环支持(ST-MCS)可使术中血流动力学更加稳定,从而提高介入治疗的安全性和有效性。然而,高昂的费用可能会限制其在资源有限环境中的使用。为了克服这一限制,我们设想了一种改良的、低成本的静脉-动脉体外膜氧合器(V-A ECMO)装置:我们进行了一项前瞻性观察研究,研究对象包括在我院接受预防性 ST-MCS 的高风险介入心脏病学手术的所有患者,使用的是改良的低成本版 V-A ECMO,其中标准 V-A ECMO 电路的部分组件由心脏外科心肺旁路所用的耗材取代,成本降低了 72%。我们评估了院内和中期结果,包括手术成功率、术后并发症和死亡率:2016 年 3 月至 2021 年 12 月期间,10 名患者接受了高风险 IC 手术,并预防性使用了 V-A ECMO。六名患者接受了单独的经皮介入手术(PCI),两名患者接受了单独的经导管主动脉瓣置换术(TAVR),两名患者接受了联合手术(PCI + TAVR)。平均射血分数为 34%(范围为 20-64%)。平均STS PROM为16.2%(范围9.5-35.8%),平均EuroScore为23.7%(范围1.5-60%)。所有病例均成功实施了计划中的介入治疗。没有关于 V-A ECMO 故障的报告。有九名患者在手术后立即撤除了 VA-ECMO,但有一名患者需要延长 24 小时的支持,但没有出现重大问题。一名患者发生了围手术期心肌梗塞,另一名患者出现了股骨假性动脉瘤。住院和30天存活率均为100%,1年存活率为80%:结论:介入心脏病学中的高风险手术可在预防性 ST-MCS 下使用改良的低成本 V-A ECMO 成功实施,适用于资源有限的环境。
{"title":"Outcomes of a modified, low-cost, veno-arterial extracorporeal membrane oxygenation (V-A ECMO) for elective, periprocedural support of high-risk percutaneous cardiac interventions: An experience from a latinamerican center.","authors":"Juan F Bulnes, Alejandro Martínez, Pablo Sepúlveda, Alberto Fuensalida, Santiago Besa, Luis Garrido, Gonzalo Martínez","doi":"10.1177/02676591231178413","DOIUrl":"10.1177/02676591231178413","url":null,"abstract":"<p><strong>Introduction: </strong>High-risk procedures in interventional cardiology include a wide spectrum of clinical and anatomical scenarios related to a higher periprocedural morbidity and mortality. The prophylactic use of short-term mechanical circulatory support (ST-MCS) may improve both the safety and efficacy of the intervention by leading to more stable procedural hemodynamics. However, the significant costs may limit its use in resource constrained settings. To overcome this limitation, we ideated a modified, low-cost, veno-arterial extracorporeal membrane oxygenator (V-A ECMO) setup.</p><p><strong>Methods: </strong>We conducted an observational prospective study including all patients undergoing a high-risk interventional cardiology procedure at our institution under prophylactic ST-MCS using a modified, low-cost version of V-A ECMO, where some components of the standard V-A ECMO circuit were replaced by supplies used for cardiac surgical cardiopulmonary bypass, achieving a cost reduction of 72%. We assessed in-hospital and mid-term outcomes, including procedural success, post-procedure complications and mortality.</p><p><strong>Results: </strong>Between March 2016 and December 2021, ten patients underwent high-risk IC procedures with prophylactic use of V-A ECMO. Isolated percutaneous intervention (PCI) was performed in six patients, isolated transcatheter aortic valve replacement (TAVR) in two, and a combined procedure (PCI + TAVR) in two. Mean ejection fraction was 34% (range 20-64%). Mean STS PROM was 16.2% (range 9.5-35.8%) and mean EuroScore was 23.7% (range 1.5-60%). The planned intervention was successfully performed in all cases. There were no reports of V-A ECMO malfunction. In nine patients the VA-ECMO was withdrawn immediately after the procedure but one patient required extended - 24 h - support with no significant issues. One patient experienced a periprocedural myocardial infarction and another developed a femoral pseudoaneurysm. In-hospital and 30-day survival were 100%, and 1-year survival was 80%.</p><p><strong>Conclusions: </strong>High-risk procedures in interventional cardiology can be successfully performed under prophylactic ST-MCS using a modified, low-cost V-A ECMO, suitable for limited-resource settings.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9570470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Perfusion-Uk
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1